An MSN-PEG-IP drug delivery system and IL13Rα2 as targeted therapy for glioma.
Sign Up to like & getrecommendations! Published in 2017 at "Nanoscale"
DOI: 10.1039/c6nr08786h
Abstract: A combination of gene therapy and chemotherapy has recently received interest as a targeted therapy for glioma. A mesoporous silica nanoparticle (MSN)-based vehicle coated with IL13Rα2-targeted peptide (IP) using polyethylene glycol (PEG), MSN-PEG-IP (MPI), was… read more here.
Keywords: il13r; glioma; targeted therapy; msn ... See more keywords